Navamedic increases the consideration to SEK 8.50 in cash per share in its unconditional public offer and convenes an extraordinary general meeting of Sensidose Aktiebolag

OSLO, Norway, May 10, 2023 /PRNewswire/ — Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-quality products to hospitals and pharmacies, has today amended its cash offer to acquire the shares and warrants in Sensidose AB not already owned by Navamedic ASA (the…